Growing community of inventors

Tianjin, China

Yingmei Han

Average Co-Inventor Count = 11.48

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Yingmei HanGuangping Xia (2 patents)Yingmei HanNaxia Zhao (2 patents)Yingmei HanPeng Liu (1 patent)Yingmei HanLida Tang (1 patent)Yingmei HanWeiren Xu (1 patent)Yingmei HanWei Liu (1 patent)Yingmei HanYuli Wang (1 patent)Yingmei HanYuquan Li (1 patent)Yingmei HanBingni Liu (1 patent)Yingmei HanShijun Zhang (1 patent)Yingmei HanXuyuan Liu (1 patent)Yingmei HanZhuanyou Zhao (1 patent)Yingmei HanWeiting Wang (1 patent)Yingmei HanQian Shang (1 patent)Yingmei HanXiaoli Fu (1 patent)Yingmei HanWeiling Kong (1 patent)Yingmei HanJing Jin (1 patent)Yingmei HanXiaohua Kong (1 patent)Yingmei HanWulin Liu (1 patent)Yingmei HanYingmei Han (2 patents)Guangping XiaGuangping Xia (2 patents)Naxia ZhaoNaxia Zhao (2 patents)Peng LiuPeng Liu (19 patents)Lida TangLida Tang (12 patents)Weiren XuWeiren Xu (10 patents)Wei LiuWei Liu (9 patents)Yuli WangYuli Wang (7 patents)Yuquan LiYuquan Li (5 patents)Bingni LiuBingni Liu (5 patents)Shijun ZhangShijun Zhang (4 patents)Xuyuan LiuXuyuan Liu (3 patents)Zhuanyou ZhaoZhuanyou Zhao (2 patents)Weiting WangWeiting Wang (2 patents)Qian ShangQian Shang (2 patents)Xiaoli FuXiaoli Fu (1 patent)Weiling KongWeiling Kong (1 patent)Jing JinJing Jin (1 patent)Xiaohua KongXiaohua Kong (1 patent)Wulin LiuWulin Liu (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Tianjin Institute of Pharmaceutical Research (1 from 9 patents)

2. Tianjin Institute of Pharmaceutical Research Co., Ltd. (1 from 5 patents)


2 patents:

1. 12257287 - Glucagon-derived peptide and use thereof

2. 8835134 - Cycloastragenol monoglucoside, preparation, pharmaceutical composition and application thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/9/2025
Loading…